Attitudes, beliefs, and practices among Swiss chiropractors regarding medication prescribing for musculoskeletal conditions: a national Q-methodology study.
Adult
Analgesics
/ therapeutic use
Anti-Inflammatory Agents
/ therapeutic use
Attitude of Health Personnel
Chiropractic
Cross-Sectional Studies
Drug Prescriptions
/ statistics & numerical data
Female
Humans
Male
Middle Aged
Musculoskeletal Diseases
/ drug therapy
Neuromuscular Agents
/ therapeutic use
Physicians
/ psychology
Practice Patterns, Physicians'
/ statistics & numerical data
Surveys and Questionnaires
Switzerland
Attitudes
Beliefs
Chiropractic
Drug prescription
Q-methodology
Switzerland
Journal
Chiropractic & manual therapies
ISSN: 2045-709X
Titre abrégé: Chiropr Man Therap
Pays: England
ID NLM: 101551481
Informations de publication
Date de publication:
20 10 2020
20 10 2020
Historique:
received:
14
05
2020
accepted:
04
10
2020
entrez:
20
10
2020
pubmed:
21
10
2020
medline:
27
2
2021
Statut:
epublish
Résumé
Swiss chiropractors have been licensed since 1995 to prescribe from a limited formulary of medications for treating musculoskeletal (MSK) conditions. In January 2018, this formulary was expanded to include additional muscle relaxant, analgesic, and anti-inflammatory medications. Internationally, controversy remains over whether or not medication prescribing should be pursued within the chiropractic profession. The purpose of this study was to assess Swiss chiropractors' attitudes, beliefs, and practices regarding their existing medication prescription privileges. This information will provide new insights on the topic and help inform research and policy discussions about expanding chiropractic prescription rights in other jurisdictions. A 13-item questionnaire and Q-methodology approach were used to conduct the assessment. Recruitment was conducted by e-mail between December 2019 and February 2020, and all members of the Swiss Chiropractic Association were eligible to participate. Data were analyzed using by-person factor analysis and descriptive statistics. In total, 187 Swiss chiropractors participated in this study (65.4% response rate). Respondents reported prescribing analgesics, anti-inflammatories, and muscle relaxants to a median of 5, 5, and 0% of patients, respectively. Forty-two percent of respondents expressed interest in further expanding the range of current medications available to Swiss chiropractors for treating MSK conditions. Only 15% expressed interest in expanding this range to include medications for treating non-MSK conditions. In the Q-methodology analysis, four salient viewpoints/groups regarding medication prescribing emerged: prescribers, non-prescribers, collaborators, and integrators. All except non-prescribers thought medication prescription privileges were advantageous for the chiropractic profession in Switzerland. There was also strong consensus among all four groups that medication prescribing should not replace manual therapy in chiropractic practice. This was the first national survey on attitudes toward prescribing medications among Swiss chiropractors since the year 2000, and the first using Q-methodology. With this approach, four unique groups of chiropractic prescribers were identified. Even with diversity among clinicians, the findings of this study showed general support for, along with conservative use of, prescribing privileges within the Swiss chiropractic profession. Studies in jurisdictions outside of Switzerland are needed to assess whether chiropractors are interested in expanding their scopes of practice to include similar prescribing privileges.
Sections du résumé
BACKGROUND
Swiss chiropractors have been licensed since 1995 to prescribe from a limited formulary of medications for treating musculoskeletal (MSK) conditions. In January 2018, this formulary was expanded to include additional muscle relaxant, analgesic, and anti-inflammatory medications. Internationally, controversy remains over whether or not medication prescribing should be pursued within the chiropractic profession.
OBJECTIVE
The purpose of this study was to assess Swiss chiropractors' attitudes, beliefs, and practices regarding their existing medication prescription privileges. This information will provide new insights on the topic and help inform research and policy discussions about expanding chiropractic prescription rights in other jurisdictions.
METHODS
A 13-item questionnaire and Q-methodology approach were used to conduct the assessment. Recruitment was conducted by e-mail between December 2019 and February 2020, and all members of the Swiss Chiropractic Association were eligible to participate. Data were analyzed using by-person factor analysis and descriptive statistics.
RESULTS
In total, 187 Swiss chiropractors participated in this study (65.4% response rate). Respondents reported prescribing analgesics, anti-inflammatories, and muscle relaxants to a median of 5, 5, and 0% of patients, respectively. Forty-two percent of respondents expressed interest in further expanding the range of current medications available to Swiss chiropractors for treating MSK conditions. Only 15% expressed interest in expanding this range to include medications for treating non-MSK conditions. In the Q-methodology analysis, four salient viewpoints/groups regarding medication prescribing emerged: prescribers, non-prescribers, collaborators, and integrators. All except non-prescribers thought medication prescription privileges were advantageous for the chiropractic profession in Switzerland. There was also strong consensus among all four groups that medication prescribing should not replace manual therapy in chiropractic practice.
CONCLUSION
This was the first national survey on attitudes toward prescribing medications among Swiss chiropractors since the year 2000, and the first using Q-methodology. With this approach, four unique groups of chiropractic prescribers were identified. Even with diversity among clinicians, the findings of this study showed general support for, along with conservative use of, prescribing privileges within the Swiss chiropractic profession. Studies in jurisdictions outside of Switzerland are needed to assess whether chiropractors are interested in expanding their scopes of practice to include similar prescribing privileges.
Identifiants
pubmed: 33076943
doi: 10.1186/s12998-020-00341-6
pii: 10.1186/s12998-020-00341-6
pmc: PMC7574492
doi:
Substances chimiques
Analgesics
0
Anti-Inflammatory Agents
0
Neuromuscular Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
54Références
J Manipulative Physiol Ther. 2010 Mar-Apr;33(3):231-7
pubmed: 20350678
J Can Chiropr Assoc. 2016 Mar;60(1):13-20
pubmed: 27069262
J Can Chiropr Assoc. 2013 Dec;57(4):285-91
pubmed: 24302774
Pain Physician. 2012 Jul;15(3 Suppl):ES9-38
pubmed: 22786464
J Chiropr Educ. 2018 Oct;32(2):115-125
pubmed: 29509506
Chiropr Man Therap. 2015 Feb 02;23(1):4
pubmed: 25646145
Chiropr Man Therap. 2019 Jul 24;27:36
pubmed: 31367341
J Physiother. 2017 Oct;63(4):221-234
pubmed: 28986140
Chiropr Man Therap. 2016 Aug 24;24(1):33
pubmed: 27559468
J Manipulative Physiol Ther. 2010 Sep;33(7):519-35
pubmed: 20937430
West J Nurs Res. 2008 Oct;30(6):759-73
pubmed: 18337548
J Can Chiropr Assoc. 2020 Aug;64(2):119-130
pubmed: 33012811
Chiropr Man Therap. 2015 Jul 15;23:22
pubmed: 26180630
Chiropr Man Therap. 2014 Sep 24;22(1):34
pubmed: 25279137
Lancet. 2017 Jul 29;390(10093):437-439
pubmed: 28792397
Chiropr Osteopat. 2005 Jul 06;13:9
pubmed: 16000175
Spine J. 2010 Dec;10(12):1055-64
pubmed: 20889389
Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):224-233
pubmed: 29911818
Chiropr Man Therap. 2016 Jun 30;24:26
pubmed: 27366317
J Chiropr Med. 2011 Mar;10(1):12-7
pubmed: 22027203
J Manipulative Physiol Ther. 2015 Sep;38(7):477-83
pubmed: 26288262
J Chiropr Med. 2019 Dec;18(4):286-298
pubmed: 32952474
Lancet. 2018 Jun 9;391(10137):2368-2383
pubmed: 29573872